Patent ID: 7998996

Claim:
Substituted pyrazoline compounds of formula I, wherein R 1 represents hydrogen or a linear or branched C 1-4 -alkyl group, R 2 , R 3 and R 4 independently of each other represent hydrogen, a linear or branched C 1-6 -alkyl group, a linear or branched C 1-6 -alkoxy group, a halogen atom, CH 2 F, CHF 2 , CF 3 , CN, OH, NO 2 , —(C═O)—R 8 , SH, SR 8 , SOR 8 , SO 2 R 8 , NH 2 , NHR 8 , NR 8 R 9 , —(C═O)—NH 2 , —(C═O)—NHR 8 or —(C═O)—NR 8 R 9 whereby R 8 and R 9 for each substituent independently represent linear or branched C 1-6 alkyl, R 5 and R 6 independently of each other represent a linear or branched C 1-6 -alkoxy group, a halogen atom, CH 2 F, CHF 2 , CF 3 , CN, OH, NO 2 , —(C═O)—R 10 , SH, SR 10 , SOR 10 , NH 2 , NHR 10 , NR 10 R 11 , —(C═O)—NH 2 , —(C═O)—NHR 10 or —(C═O)—NR 10 R 11 , whereby R 10 and optionally R 11 for each substituent independently represent linear or branched C 1-6 alkyl; R 7 represents hydrogen, a linear or branched C 1-6 -alkyl group, a linear or branched C 1-6 -alkoxy group, a halogen atom, CH 2 F, CHF 2 , CF 3 , CN, OH, NO 2 , —(C═O)—R 10 , SH, SR 10 , SOR 10 , NH 2 , NHR 10 , NR 10 R 11 —(C═O)—NH 2 , —(C═O)NHR 10 or —(C═O)—NR 10 R 11 , whereby R 10 and optionally R 11 for each substituent independently represent linear or branched C 1-6 alkyl; with the proviso that if R 1 and R 7 are H and R 5 and R 6 both represent Cl in the 3- and 4-position of the phenyl ring neither of R 2 , R 3 and R 4 may represent F in the 4-position of the phenyl ring if the other two of R 2 , R 3 and R 4 both represent H; optionally in a form of one of its stereoisomers or a racemate or in a form of a mixture of at least two of its stereoisomers, in any mixing ratio, or a corresponding N-oxide thereof, or a physiologically acceptable salt thereof.